Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
Investigation of the clinical efficacy and safety of dual antiplatelet therapy with
clopidogrel and cilostazol versus clopidogrel alone in preventing ischemic vascular events in
patients with type 2 diabetes and symptomatic peripheral arterial disease.